News & Updates
Filter by Specialty:
Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials
13 Jun 2022
In clinical practice, patients with neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO), and retinal vein occlusion (RVO) see treatment outcomes that are inferior to those reported in pivotal phase 3 studies, according to a recent study.
Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials
13 Jun 2022Vision impairment linked to depression, anxiety among kids
06 Jun 2022
Children with vision impairment often experience greater symptoms of depression and anxiety, according to a recent study. Surgical treatment helps improve these mental health symptoms.
Vision impairment linked to depression, anxiety among kids
06 Jun 2022OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022
byAudrey Abella
In a retrospective review of real-world data from Japan, omidenepag isopropyl 0.002% ophthalmic solution (OMDI) demonstrated an intraocular pressure (IOP)-lowering effect in eyes with different types of glaucoma, without severe or serious adverse effects.